4
Changes in Ownership
Fulgent Genetics, Inc. Filed Acc 0001209191-22-035962
Options or other derivatives
- President and CEO acquired 1,000,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hsieh Ming President and CEO | 2022-06-08 | Other acquisition · Forward sale contract (obligation to sell) | +1,000,000 | 1,000,000 | I | ||
Loading xslF345X03/doc4.xml…